BioSpace News Archive

Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced that the Company’s Chief Operating Officer, Taneli Jouhikainen, will present at the Canaccord Genuity Global Growth Conference on Wednesday, August 7, 2019 at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time in the Montreal Room at the Intercontinental in Boston.

RaySearch has been developing world-class software since 2000, at first selling advanced calculation modules to other vendors.

Stock will begin trading on the Nasdaq Capital Market under the symbol “XCUR” at the opening of trading on July 31, 2019, following its previously announced approval to list its common stock on the Nasdaq Capital Market.

MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon’s entire portfolio of assets in Greater China [31-July-2019] ST. LOUIS , July 31, 2019 /PRNewswire/ -- MediBeacon Inc ., whose largest shareholder is Pansend Life Sciences, LLC, a subsidiary of HC2 Holdings, Inc. (NYSE MKT: HCHC), announced today that they have entere

Company to Fill 300 Full-Time Clinical and Operational Positions

Benitec Biopharma, a clinical-stage biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference platform combining RNA interference with gene therapy, announced its Appendix 4C for the quarter ending 31 July 2019.

UrologyLocums.com announced today the launch of the company, adding a new player to the Locums Tenens arena.

Company submits non-proprietary drug name selections to United States Adopted Names Council

DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE:DYME; OTCQB:DYMEF), a multi-state cannabis brands, distribution and delivery platform, today announced an exclusive distribution agreement with Long Beach, California-based manufacturer, Woah Candy Co., to bring its cannabis-infused caramels and chocolate edibles to consumers throughout California.

Omeros and Lonza have successfully partnered under a multi-year manufacturing agreement for the clinical supply of narsoplimab.